Match tier Institution-verified
Presence Current · Arkansas
Last published 2025
Sources Institutional record
Refreshed 2026-08-15
Weida Tong profile photo

Weida Tong

Sourced from institutional research profiles (UAMS TRI or ARA).

◆ ARA Academy

Division Director

Also affiliated: United States Food and Drug Administration (2020–2021); Sunnybrook Health Science Centre (2020); Center for Devices and Radiological Health (2020); Rhode Island Hospital (2021); Office of Science (2020); Fudan University Shanghai Cancer Center (2020); Mayo Clinic in Arizona (2009); Lifespan (2021); Sunnybrook Research Institute (2020)

Faculty Researcher

4 h-index 11 pubs 687 cited

  • Humans
  • Animals
  • Gene Expression Profiling
  • Oligonucleotide Array Sequence Analysis
  • Algorithms
  • Chemical and Drug Induced Liver Injury
  • Drug-Related Side Effects and Adverse Reactions
  • United States
  • United States Food and Drug Administration
  • Reproducibility of Results
  • Artificial Intelligence
  • High-Throughput Nucleotide Sequencing
  • Computational Biology
  • Rats
  • Software

Edit your profile

Biography and Research Information

OverviewAI-generated summary

Weida Tong leads a research group focused on regulatory science, with a particular emphasis on the application of bioinformatics and emerging technologies. Tong's work investigates the impact of new technologies on regulatory science and explores the use of AI-based language models in drug discovery and development. This research area intersects with public health and the evaluation of scientific reporting guidelines, such as the STORMS checklist for human microbiome research.

Further research interests include the regulatory landscape of nanotechnology and nanoplastics, and the analytical validation of sequencing assays for precision oncology. Tong has a scholarly record with an h-index of 4, encompassing 11 publications and 640 citations. Key collaborators at the National Center for Toxicological Research include Joshua Xu (14 shared publications), Leihong Wu (7 shared publications), William Slikker (4 shared publications), and Binsheng Gong (4 shared publications). Tong is also recognized as an ARA Academy member (ARA Fellow).

Metrics

  • h-index: 4
  • Publications: 11
  • Citations: 687

Selected Publications

  • Is regulatory science ready for artificial intelligence? (2025)
    npj Digital Medicine 38 citations DOI OpenAlex
  • AI-powered topic modeling: comparing LDA and BERTopic in analyzing opioid-related cardiovascular risks in women (2025)
    Experimental Biology and Medicine 49 citations DOI OpenAlex
  • Is ChatGPT Ready for Public Use in Organ-Specific Drug Toxicity Research? (2025)
    2 citations DOI OpenAlex
  • Bridging organ transcriptomics for advancing multiple organ toxicity assessment with a generative AI approach (2024)
    14 citations DOI OpenAlex
  • Physiological liver microtissue 384-well microplate system for preclinical hepatotoxicity assessment of therapeutic small molecule drugs (2024)
    20 citations DOI OpenAlex
  • Progress in toxicogenomics to protect human health (2024)
    Nature Reviews Genetics 60 citations DOI OpenAlex
  • Text summarization with ChatGPT for drug labeling documents (2024)
    13 citations DOI OpenAlex
  • Generation of a drug-induced renal injury list to facilitate the development of new approach methodologies for nephrotoxicity (2024)
    19 citations DOI OpenAlex
  • Evaluation of QSAR models for predicting mutagenicity: outcome of the Second Ames/QSAR international challenge project (2023)
    19 citations DOI OpenAlex
  • Measurement and Mitigation of Bias in Artificial Intelligence: A Narrative Literature Review for Regulatory Science (2023)
    Clinical Pharmacology & Therapeutics 33 citations DOI OpenAlex
  • Quartet DNA reference materials and datasets for comprehensively evaluating germline variant calling performance (2023)
    29 citations DOI OpenAlex
  • PLM-ARG: antibiotic resistance gene identification using a pretrained protein language model (2023)
    Bioinformatics 38 citations DOI OpenAlex
  • A generative adversarial network model alternative to animal studies for clinical pathology assessment (2023)
    Nature Communications 56 citations DOI OpenAlex
  • The Quartet Data Portal: integration of community-wide resources for multiomics quality control (2023)
    22 citations DOI OpenAlex
  • Author Correction: Quartet RNA reference materials improve the quality of transcriptomic data through ratio-based profiling (2023)
    13 citations DOI OpenAlex

View all publications on OpenAlex →

ARA Academy 2016 ARA Fellow

Dr. Tong's work emphasizes developing bioinformatic tools and methodologies to support FDA research, regulatory science, and personalized medicine. His notable initiatives include the Microarray Quality Control (MAQC) consortium, the Liver Toxicity Knowledge Base (LTKB), in silico drug repositioning for rare disease treatment, and the ArrayTrack suite for pharmacogenomics review.

Policy Impact

Develops bioinformatic tools supporting FDA regulatory science and personalized medicine, anchoring critical federal research infrastructure in Arkansas.

Growth Areas

['Population Health Innovations & Clinical Research']

Collaboration Network

360 Collaborators 172 Institutions 20 Countries

Top Collaborators

View profile →
View profile →

Similar Researchers

Based on overlapping research topics